Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand

Overview

The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 2012

Detailed Description

MC MD

Clinical Trial Outcome Measures

Primary Measures

  • Changes in PEF and overall CCQ score
    • Time Frame: between the first visit and after 12 (plus or minus 1) weeks

Secondary Measures

  • Difference of the changes of PEF and overall CCQ score comparing between various treatments
    • Time Frame: between the first visit and after 12 (plus or minus 1) weeks

Participating in This Clinical Trial

Inclusion Criteria

1. Provision of informed consent prior to any study specific procedures 2. Male or non-pregnant female aged >40 years 3. A clinical diagnosis of COPD with FEV1/ FVC <0.70 and require combination or modified therapy 4. Smoke > 10 Pack Year Exclusion Criteria:

1. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) 2. Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months

Gender Eligibility: All

Minimum Age: 41 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • AstraZeneca
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Assoc. Prof. Watchara Boonsawat, Principal Investigator, Khon Kaen University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.